Related Experiment Video
Updated: Mar 19, 2026

Location, Dissection, and Analysis of the Murine Stellate Ganglion
Published on: December 22, 2020
Pharmacologic Management of Ventricular Arrhythmias: Targeting Nicotinic Signaling Mechanisms
Nikhil Ahluwalia1, Peter Hanna2, Kalyanam Shivkumar2
1Electrophysiology Department, Barts Heart Centre, St Bartholomew's Hospital, London, United Kingdom; Institute of Cardiovascular Science, University College, London, United Kingdom.
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

